Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Extended criteria and NHB organ donation

F Delmonico

Ann Transplant 2009; 14(1): 19-19 :: ID: 880520

Abstract

An "expanded" criteria donor (ECD) kidney is defi ned in the United States by the Organ Procurement and Transplantation Network (OPTN) as a kidney re-covered from a deceased donor of age 60 years or greater, or a donor between 50 and 59 years of age who meets at least two of the following criteria: a terminal pre-recovery serum creatinine >1.5 mg/dl, a cerebrovascular accident as the cause of death, or a history of hypertension. Kidneys transplanted from an ECD have a relative risk (RR) of allograft failure that is ≥70% greater than that of kidneys transplanted from an "ideal" reference group of non-hypertensive deceased donors between the ages of 10 and 39 years with a terminal serum creatinine of less than 1.5 mg/dl and death from a cause other than a cerebral vascular accident. Since the inception of the ECD allocation system in 2002 there has been a national ECD kidney discard rate of 40%, significantly higher than the 9% discard rate observed for SCD kidneys. Non-recovery of ECD kidneys or discard of recovered ECD kidneys would be justified if the observed outcome for such kidneys was dramatically poor; but with the exception of kidneys from donors aged 70 years or older and percent GS >20%, a recently completed study data did not reveal any significant association between those characteristics that appear to contribute to the decision to discard an ECD kidney and post-transplant outcomes. Therefore, practice as it relates to discard often appears to be unjustified by actual transplant outcomes. There is an expansion of donation at the cardiac death in the United States attributed to changing societal attitude and practices in the intensive care unit that are leading to withdrawal of futile treatment before a brain death determination is made. The consequence of these developments has been a reduction in the eligible deceased organ donors in the United States.

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358